On March 20, 2018 Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug-resistant (MDR) infections, reported that company management will give a corporate presentation at the 17th Annual Needham Healthcare Conference on Tuesday, March 27 at 11:00 a.m. Eastern Time at the Westin New York Grand Central Hotel in New York City (Press release, Tetraphase, MAR 20, 2018, View Source [SID1234524915]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Live audio webcasts of the presentation will be available on the company’s website at View Source Archived presentations will be available for 30 days.